Skip to main content
Erschienen in: European Journal of Epidemiology 9/2011

01.09.2011 | NEURO-EPIDEMIOLOGY

Changing mortality for motor neuron disease in France (1968–2007): an age-period-cohort analysis

verfasst von: Paul H. Gordon, Fanny Artaud, Albertine Aouba, Françoise Laurent, Vincent Meininger, Alexis Elbaz

Erschienen in: European Journal of Epidemiology | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

The incidence and mortality of motor neuron disease (MND) increase with age and appear to have increased with time. The examination of period and cohort effects using age-period-cohort (APC) models can help characterize temporal trends. Our objective was to describe mortality from MND in France (1968–2007), and to examine the role of age, period of death, and birth-cohort on changes in mortality. The number of people who died from MND and population statistics (1968–2007) were extracted from French national records. Annual standardized (age/sex) mortality ratios (SMRs) were computed. Using Poisson regression, APC models examined the relationship between mortality rates and age, period of death, and birth-cohort in subjects aged 40–89 years. Deviance/degrees-of-freedom ratios evaluated model fit; ratios close to one indicated adequate fit. Between 1968 and 2007, 38,863 individuals died from MND (mortality rate = 1.74/100,000); 37,624 were aged 40–89 years. SMRs increased from 54 (95% CI = 49–59) in 1968 to 126 (120–132) in 2007. Male-to-female ratios declined from 1.80 in 1968 to 1.45 in 2007. Changing mortality rates were best explained by cohort effects (deviance/degrees-of-freedom = 1.09). The relative risk of dying from MND increased markedly for persons born between 1880 and 1920, and more slowly after 1920. In conclusion, mortality rates for MND increased between 1968 and 2007, and more rapidly in women than men. This increase was better explained by the birth-cohort of individuals than by period effects. Changing environmental exposures may be a possible explanation and these findings warrant the continued search for environmental risk factors for MND.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985–1988. Arch Neurol. 1991;48:589–93.PubMed Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985–1988. Arch Neurol. 1991;48:589–93.PubMed
2.
Zurück zum Zitat Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.PubMedCrossRef Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.PubMedCrossRef
3.
Zurück zum Zitat Marin B, Gil J, Preux PM, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotroph Later Scler. 2009;10:216–20.CrossRef Marin B, Gil J, Preux PM, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotroph Later Scler. 2009;10:216–20.CrossRef
4.
Zurück zum Zitat Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.PubMedCrossRef Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.PubMedCrossRef
5.
Zurück zum Zitat Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.PubMedCrossRef Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.PubMedCrossRef
6.
Zurück zum Zitat Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol. 2009;66:515–9.PubMedCrossRef Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol. 2009;66:515–9.PubMedCrossRef
7.
Zurück zum Zitat Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.PubMedCrossRef Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.PubMedCrossRef
8.
Zurück zum Zitat Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002;59:280–2.PubMed Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002;59:280–2.PubMed
9.
Zurück zum Zitat Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683–9.PubMed Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683–9.PubMed
10.
Zurück zum Zitat Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.PubMed Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.PubMed
11.
Zurück zum Zitat Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand. 2001;104:232–5.PubMedCrossRef Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand. 2001;104:232–5.PubMedCrossRef
12.
Zurück zum Zitat Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.PubMedCrossRef Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.PubMedCrossRef
13.
Zurück zum Zitat Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151:156–63.PubMed Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151:156–63.PubMed
14.
Zurück zum Zitat Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65:378–85.PubMedCrossRef Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65:378–85.PubMedCrossRef
15.
Zurück zum Zitat Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773–5.PubMed Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773–5.PubMed
16.
Zurück zum Zitat Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Later Scler. 2009;10:302–9.CrossRef Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Later Scler. 2009;10:302–9.CrossRef
17.
Zurück zum Zitat Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med. 1987;6:449–67.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med. 1987;6:449–67.PubMedCrossRef
18.
Zurück zum Zitat Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med. 1987;6:469–81.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med. 1987;6:469–81.PubMedCrossRef
19.
Zurück zum Zitat Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989;39:768–73.PubMed Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989;39:768–73.PubMed
20.
Zurück zum Zitat Hill C, Doyon F. Age in completed years versus age reached during the year. Rev Epidemiol Sante Publique. 2005;53:205–8.PubMedCrossRef Hill C, Doyon F. Age in completed years versus age reached during the year. Rev Epidemiol Sante Publique. 2005;53:205–8.PubMedCrossRef
21.
Zurück zum Zitat Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39:311–24.PubMedCrossRef Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39:311–24.PubMedCrossRef
22.
23.
Zurück zum Zitat Dean G, Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatr. 1993;56:633–7.PubMedCrossRef Dean G, Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatr. 1993;56:633–7.PubMedCrossRef
24.
Zurück zum Zitat Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology. 1993;43:927–30.PubMed Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology. 1993;43:927–30.PubMed
25.
Zurück zum Zitat O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatr. 2008;79:30–2.PubMedCrossRef O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatr. 2008;79:30–2.PubMedCrossRef
26.
Zurück zum Zitat Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D’Alessandro R, et al. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Neuroepidemiology. 2004;23:73–7.PubMedCrossRef Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D’Alessandro R, et al. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Neuroepidemiology. 2004;23:73–7.PubMedCrossRef
27.
Zurück zum Zitat Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the US, 1977–1986: evidence for an inherently susceptible population subset. Mech Ageing Dev. 1990;55:207–20.PubMedCrossRef Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the US, 1977–1986: evidence for an inherently susceptible population subset. Mech Ageing Dev. 1990;55:207–20.PubMedCrossRef
28.
Zurück zum Zitat Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448–55.PubMedCrossRef Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448–55.PubMedCrossRef
29.
Zurück zum Zitat Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517–8.PubMedCrossRef Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517–8.PubMedCrossRef
30.
Zurück zum Zitat Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci. 1977;32:411–24.PubMedCrossRef Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci. 1977;32:411–24.PubMedCrossRef
31.
Zurück zum Zitat Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5–8.PubMedCrossRef Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5–8.PubMedCrossRef
32.
Zurück zum Zitat Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925–1977. Neurology. 1980;30:463–70.PubMed Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925–1977. Neurology. 1980;30:463–70.PubMed
33.
Zurück zum Zitat Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980;30:453–62.PubMed Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980;30:453–62.PubMed
34.
Zurück zum Zitat Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.PubMedCrossRef Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.PubMedCrossRef
35.
Zurück zum Zitat Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000;53:1025–9.PubMedCrossRef Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000;53:1025–9.PubMedCrossRef
36.
Zurück zum Zitat Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatr. 2010;81:385–90.PubMedCrossRef Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatr. 2010;81:385–90.PubMedCrossRef
Metadaten
Titel
Changing mortality for motor neuron disease in France (1968–2007): an age-period-cohort analysis
verfasst von
Paul H. Gordon
Fanny Artaud
Albertine Aouba
Françoise Laurent
Vincent Meininger
Alexis Elbaz
Publikationsdatum
01.09.2011
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 9/2011
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9595-0

Weitere Artikel der Ausgabe 9/2011

European Journal of Epidemiology 9/2011 Zur Ausgabe